Related Experiment Video

Updated: May 7, 2026

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

The multiple roles of microRNA-155 in oncogenesis

Gadareth Higgs1, Frank Slack

  • 1Yale Center for Medical Informatics, Yale University, Suite 505, 300 George Street, New Haven, USA. gadareth.higgs@yale.edu.

Journal of Clinical Bioinformatics
|October 1, 2013
PubMed

Insights

MicroRNA miR-155 is frequently overexpressed in cancers and promotes oncogenesis. Anti-miR-155 therapies show promise for cancer treatment, despite some debate on miR-155

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Regulation

Background:

  • MicroRNA miR-155 is a key player in cancer biology, notably overexpressed in many malignancies.
  • miR-155 has been linked to the promotion of various cancers, including breast, lung, liver, and lymphatic system cancers.
  • The role of microRNAs (miRNAs) in tumorigenesis is an active area of research and debate.

Purpose of the Study:

  • To review and synthesize recent research on the role of miR-155 in oncogenesis.
  • To analyze miR-155's association with cancer, its interactions with other miRNAs, and mechanisms of action.
  • To discuss promising therapeutic strategies targeting miR-155.

Main Methods:

  • Literature review synthesizing information from ten recent scientific papers.
  • Analysis of existing data on miR-155's role in cancer development.
  • Discussion of current controversies and therapeutic implications.

Main Results:

  • The majority of reviewed studies confirm miR-155's oncogenic role.
  • miR-155 is implicated in promoting breast, lung, liver, and lymphatic cancers.
  • Emerging research suggests potential anti-oncogenic or pro-immunological roles for miR-155, though this is debated.

Conclusions:

  • miR-155 plays a significant role in oncogenesis across multiple cancer types.
  • Targeted therapies, particularly anti-miR-155 strategies, represent promising avenues for cancer treatment.
  • Further research is needed to fully elucidate miR-155's complex functions and therapeutic potential.

More Related Videos

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...